These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30893264)

  • 21. The Diverse Function of PD-1/PD-L Pathway Beyond Cancer.
    Qin W; Hu L; Zhang X; Jiang S; Li J; Zhang Z; Wang X
    Front Immunol; 2019; 10():2298. PubMed ID: 31636634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.
    Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS
    J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection.
    Zheng X; Dong L; Wang K; Zou H; Zhao S; Wang Y; Wang G
    Ann Surg Oncol; 2019 Mar; 26(3):884-893. PubMed ID: 30565043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
    Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H
    Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmed Cell Death Ligand 1 Expression Is an Independent Prognostic Factor in Colorectal Cancer.
    Enkhbat T; Nishi M; Takasu C; Yoshikawa K; Jun H; Tokunaga T; Kashihara H; Ishikawa D; Shimada M
    Anticancer Res; 2018 Jun; 38(6):3367-3373. PubMed ID: 29848685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.
    Gianchecchi E; Delfino DV; Fierabracci A
    Autoimmun Rev; 2013 Sep; 12(11):1091-100. PubMed ID: 23792703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
    Menguy S; Prochazkova-Carlotti M; Beylot-Barry M; Saltel F; Vergier B; Merlio JP; Pham-Ledard A
    Am J Surg Pathol; 2018 Mar; 42(3):326-334. PubMed ID: 29112015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer.
    Funaki S; Shintani Y; Kawamura T; Kanzaki R; Minami M; Okumura M
    Oncol Rep; 2017 Oct; 38(4):2277-2284. PubMed ID: 28849209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction.
    Okuyama M; Mezawa H; Kawai T; Urashima M
    Front Immunol; 2019; 10():86. PubMed ID: 30833943
    [No Abstract]   [Full Text] [Related]  

  • 30. PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis.
    Nie M; Liu Y; Li XX; Min YN; Yang DD; Li Q; Feng Q; Hou Y; Li GS; Sun JZ; Hou M; Shi Y
    Thromb Haemost; 2019 May; 119(5):758-765. PubMed ID: 30808044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte programmed death ligand-1 expression is an early marker for predicting infectious complications in acute pancreatitis.
    Pan T; Zhou T; Li L; Liu Z; Chen Y; Mao E; Li M; Qu H; Liu J
    Crit Care; 2017 Jul; 21(1):186. PubMed ID: 28705256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical trauma induces postoperative T-cell dysfunction in lung cancer patients through the programmed death-1 pathway.
    Xu P; Zhang P; Sun Z; Wang Y; Chen J; Miao C
    Cancer Immunol Immunother; 2015 Nov; 64(11):1383-92. PubMed ID: 26183035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
    Yang MW; Fu XL; Jiang YS; Chen XJ; Tao LY; Yang JY; Huo YM; Liu W; Zhang JF; Liu PF; Liu Q; Hua R; Zhang ZG; Sun YW; Liu DJ
    World J Gastroenterol; 2019 Apr; 25(14):1684-1696. PubMed ID: 31011254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages.
    Cheng L; Liu J; Liu Q; Liu Y; Fan L; Wang F; Yu H; Li Y; Bu L; Li X; Wei W; Wang H; Sun G
    Int J Biol Sci; 2017; 13(6):723-734. PubMed ID: 28655998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells.
    Dong L; Lv H; Li W; Song Z; Li L; Zhou S; Qiu L; Qian Z; Liu X; Feng L; Meng B; Fu K; Wang X; Pan-Hammarström Q; Wang P; Wang X; Zhang H
    Oncotarget; 2016 May; 7(22):33350-62. PubMed ID: 27147575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced Programmed Death 1 and Diminished Programmed Death Ligand 1 Up-Regulation Capacity of Post-Activated Lupus B Cells.
    Stefanski AL; Wiedemann A; Reiter K; Hiepe F; Lino AC; Dörner T
    Arthritis Rheumatol; 2019 Sep; 71(9):1539-1544. PubMed ID: 30919595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma.
    Harada K; Dong X; Estrella JS; Correa AM; Xu Y; Hofstetter WL; Sudo K; Onodera H; Suzuki K; Suzuki A; Johnson RL; Wang Z; Song S; Ajani JA
    Gastric Cancer; 2018 Jan; 21(1):31-40. PubMed ID: 28801853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
    Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
    Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19
    Wang Z; Tan F
    Scand J Immunol; 2020 Feb; 91(2):e12836. PubMed ID: 31598989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-1/PD-L1 regulates Treg differentiation in pregnancy-induced hypertension.
    Jiang L; Tang C; Gong Y; Liu Y; Rao J; Chen S; Qu W; Wu D; Lei L; Chen L
    Braz J Med Biol Res; 2018; 51(8):e7334. PubMed ID: 29846432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.